Company attributes
Location
Legal Name
Debiopharm Innovation Fund S.A.
Parent Organization
Founded Date
2008
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Debiopharm Innovation Fund - also known as Debiopharm Diagnostics - is the venture capital subsidiary of Debiopharm Group. The firm has been in operations since 2008. It specializes in funding companies that are developing smart data and digital health products and services intended for drug development and patient journey in the field of oncology and infectious diseases. Debiopharm Innovation Fund prefers to fund companies during the Series A and B financing round. As of January 2020, Debiopharm Innovation Fund has invested in 19 companies and has sold off its stakes in eight of them.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
